TrialHuman vaccines & immunotherapeutics2019

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults.

Susan B Manoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.